Q3 2026: growth accelerates across most players, but the gap between leaders and laggards remains significant
The third quarter confirmed a broad improvement in the sector, with five of the six groups accelerating sequentially. However, performance remains highly differentiated, both in terms of underlying growth and profitability.
L’Oréal reinforced its market leadership, with +7.7% adjusted like-for-like growth in Q3, accelerating from +6.3% in Q2 and +6.7% in Q1. Growth was particularly strong in Europe (+8.9%), North Asia (+7.8%) and SAPMENA-SSA (+19.5%), while North America remained solid at +5.6%.
Estée Lauder’s recovery continued to gain momentum, with a particularly strong improvement in profitability. Organic sales increased +6% in Q3, compared with +5% in Q2 and +2% in Q1. The recovery was geographically broad, with Mainland China growing +9%, Asia-Pacific +10%, the Americas +4% and EUKEM +4%. Fragrance was the standout category at +20%, while Skin Care grew +4% and Makeup +1%.
Puig delivered another solid quarter, with growth reaccelerating. Like-for-like sales increased +5.6% in Q3, compared with +4.1% in Q2, supported by strong momentum in Makeup (+16.1%) and continued growth in Fragrance & Fashion (+3.9%).
Shiseido confirmed its gradual recovery, with significant profitability improvements. Like-for-like sales increased approximately +3% in Q3, following +2% in Q2 and -3% in Q1. Growth improved in China & Travel Retail (+5%), Asia-Pacific (+7%) and the Americas (+4%), while Japan remained broadly flat.
LVMH Perfumes & Cosmetics returned to modest positive growth, with +1% organic sales growth in Q3, after -1% in Q2 and 0% in Q1
Coty remained the weakest performer, with a slight sequential deterioration. Like-for-like sales declined -2% this quarter, compared with -1% in the last one. Prestige declined -1%, while Consumer Beauty remained weaker at -3%.
Stock market performance: a broad increase in beauty sector valuations
Over the past year, the market valuations of listed beauty pure players have generally increased, with share-price gains ranging from +24% to +74% as of 13 November 2026. This positive trend reflects renewed investor confidence in the sector, supported by improving growth momentum, a recovery in Asian markets and stronger profitability prospects
M&A and strategic developments – very active period!
- Puig / ISDIN: On 14 September, Puig agreed to acquire Esteve’s remaining 50% stake in ISDIN for €1.2bn, giving it full ownership upon completion. This represents a major strategic step in strengthening its position in dermocosmetics and reducing its relative dependence on fragrance.
- L’Oréal / Nykaa: In September, L’Oréal’s investment fund BOLD and Indian beauty retailer Nykaa announced a partnership to take minority stakes in emerging Indian beauty and personal care brands, illustrating increasing strategic interest in local digital-native businesses.
- Henkel / Olaplex: Henkel completed its acquisition of premium haircare brand Olaplex in July, following the announcement of a transaction valued at approximately $1.4bn. The transaction reinforces the strategic importance of science-led and premium professional haircare.
- KKR / Ci FLAVORS: KKR agreed in August to acquire Japanese beauty platform Ci FLAVORS from shareholders including L Catterton, reinforcing private equity interest in Asian beauty brands and platforms.
- Regent / Avon North America: Regent agreed in August to acquire Avon North America from LG H&H, bringing the North American and international Avon businesses back under common ownership.
- Galderma / ZO Skin Health (October): Galderma agreed to acquire ZO Skin Health for an enterprise value of $1.5bn from shareholders including Blackstone. The acquisition, expected to close in Q4 2026 or early 2027, significantly strengthens Galderma’s position in physician-dispensed skincare and underscores the growing attractiveness of medical-grade beauty.
- PAI Partners / Elemis (November): PAI Partners agreed on 4 November to acquire Elemis from L’Occitane Group for an undisclosed amount. The British prestige skincare brand generated more than $300m in FY2026 sales and has a strong presence in the US and online channels. The transaction confirms continued private equity interest in premium, science-led skincare.
- BEHN / Marionnaud (November): David Konckier, majority shareholder of Groupe Bogart, completed the acquisition of Marionnaud through his holding company BEHN on 5 November. With approximately €650m in revenues and 687 stores across eight European countries, the transaction represents a significant change in the European selective beauty retail landscape.
Ongoing M&A process to watch
- Advent / Parfums de Marly: Advent International is exploring a potential sale of Parfums de Marly, with CVC Capital Partners, Cinven and Puig among the reported interested parties.